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Toll interleukin-1 receptor (IL-1R) 8 (TIR8), also known as single Ig IL-1 receptor (IL-R)-related molecule, or SIGIRR, is a mem-
ber of the IL-1R-like family, primarily expressed by epithelial cells. Current evidence suggests that TIR8 plays a nonredundant
role as a negative regulator in vivo under different inflammatory conditions that are dependent on IL-R and Toll-like receptor
(TLR) activation. In the present study, we examined the role of TIR8 in innate resistance to acute lung infections caused by Pseu-
domonas aeruginosa, a Gram-negative pathogen responsible for life-threatening infections in immunocompromised individuals
and cystic fibrosis patients. We show that Tir8 deficiency in mice was associated with increased susceptibility to acute P. aerugi-
nosa infection, in terms of mortality and bacterial load, and to exacerbated local and systemic production of proinflammatory
cytokines (gamma interferon [IFN-], tumor necrosis factor alpha [TNF-], IL-1, and IL-6) and chemokines (CXCL1, CXCL2,
and CCL2). It has been reported that host defense against P. aeruginosa acute lung infection can be improved by blocking IL-1
since exaggerated IL-1 productionmay be harmful for the host in this infection. In agreement with these data, IL-1RI defi-
ciency rescues the phenotype observed in Tir8-deficient mice: in Tir8/ IL-1RI/ double knockout mice we observed higher
survival rates, enhanced bacterial clearance, and reduced levels of local and systemic cytokine and chemokine levels than in Tir8-
deficient mice. These results suggest that TIR8 has a nonredundant effect in modulating the inflammation caused by P. aerugi-
nosa, in particular, by negatively regulating IL-1RI signaling, which plays a major role in the pathogenesis of this infectious
disease.
Pseudomonas aeruginosa is a common pathogen in differentclinical settings. In particular, it is a frequent cause of nosoco-
mial infections in hospitalized and immunocompromised pa-
tients and the major pathogen associated with respiratory tract
infections in cystic fibrosis (CF) patients, playing a critical role in
the development and progression of pulmonary disease (12, 18).
The pathogenesis ofP. aeruginosapneumonia is complex, and the
outcome of an infection depends on the virulence factors displayed
by the bacteria as well as on the host response (46). The Toll-like
receptor (TLR)-MyD88 pathway plays nonredundant roles in resis-
tance toP. aeruginosa infection. Inparticular,TLR2,TLR4, andTLR5
and the common adaptor molecule MyD88 expressed by alveolar
macrophages,neutrophils, andepithelial cells are involved in thepro-
ductionof inflammatorymediators followingP.aeruginosa infection,
in leukocyte recruitment, and in bacterial clearance (36, 40, 52).On
the other hand, the role of interleukin-1 receptor type I (IL-1RI),
which belongs to the IL-1R-like (ILR) superfamily and also signals
through MyD88, is controversial in P. aeruginosa lung infection.
Schultz et al. showed that IL-1RI deficiency had a protective effect in
P. aeruginosa pulmonary infection and was associated with a de-
creased influx of neutrophils and lower levels of cytokines and
chemokines in the lungs (49). In contrast, Sutterwala et al. demon-
strated the protective role of the interleukin-converting enzyme
protease-activating factor (IPAF) inflammasome/caspase-1 axis in
inducing macrophage cell death and IL-1 secretion, an innate im-
mune response which is circumvented by virulent ExoU-expressing
P. aeruginosa strains (55).
The activation of the signaling cascade leading to the produc-
tion of proteins related to inflammation and immunity by ILRs or
TLRs potentially causes devastating inflammatory reactions and is
tightly regulated. For the IL-1 system, the control is exerted at
different levels, both extracellularly and intracellularly (11, 14, 30,
51). Toll IL-1R 8 (TIR8), also known as single Ig IL-1-related
receptor (SIGIRR), is a molecule acting intracellularly to inhibit
ILR and TLR signaling (14, 57). Inhibition requires the intracel-
lular portion of TIR8, possibly obtained by trapping IRAK-1 and
TRAF-6, while the extracellular domain may interfere with het-
erodimerization of IL-1R1 and IL-1 accessory protein (IL-1AcP)
(37).
Gene-targeted mice demonstrated that Tir8 acts as a nonre-
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dundant negative regulator in vivo under different inflammatory
conditionswhich are dependent on ILR andTLR activation. These
include intestinal inflammation and colon cancer (16, 17), auto-
immune diseases (29), allergic reactions (8), kidney ischemia/rep-
erfusion injury, and allotransplantation (28, 33). In infections (tu-
berculosis, fungal infections, P. aeruginosa-induced keratitis, and
endotoxemia), Tir8 emerged as a key molecule involved in damp-
ening ILR- and TLR-induced inflammation and tissue damage (6,
15, 25, 59).
In the present work, we examined the effect of Tir8 deficiency
in resistance to acute P. aeruginosa lung infection. Our results
suggest that the lack of a negative regulator of TLRs and ILR results
in exacerbated local and systemic production of proinflammatory
cytokines and chemokines, leading to increased mortality and
lung bacterial load.Moreover, results obtained inmice deficient in
both Tir8 and IL-1RI showed that the abrogation of the IL-1-
dependent inflammatory cascade reverted the phenotype of Tir8-
deficient mice.
These results suggest that the modulation of IL-1RI signaling
exerted by TIR8 has amajor role in the pathogenesis of the inflam-
mation associated with P. aeruginosa lung infection.
MATERIALS AND METHODS
Ethics statement.Procedures involving animals and their care conformed
with institutional guidelines in compliance with national (25a) and inter-
national law and policies (12a, 31)). The protocol was approved by the
ItalianMinistry ofHealth (Protocol 192/2008-B). All efforts weremade to
minimize the number of animals used and their suffering.
Animals. Tir8-deficient (Tir8/) mice were generated as described
previously (16).Mice (20 to 22 g) used in this study were 8 to 12 weeks old
and were bred on the C57BL/6J background (backcrossed for 11 genera-
tions). Wild-type controls (Tir8/) were C57BL/6J mice obtained from
Charles River Laboratories (Lyon, France). IL-1RI-deficient (IL-1R/)
mice were kindly provided by J. E. Sims (Amgen, Seattle, WA). Mice
deficient in both Tir8 and IL-1R (Tir8/ IL-1R/) were obtained by
crossing Tir8/ and IL-1R/ mice. Mice were housed in a specific-
pathogen-free (SPF) animal facility of the Istituto Clinico Humanitas in
individually ventilated cages.
Acute lung infection. The reference laboratory P. aeruginosa strain
PAO1 (54) was used. Bacteria were cultured in Trypticase soy broth (TSB)
and plated on Pseudomonas isolation agar (PIA) or Trypticase soy agar
(TSA) plates at 37°C.
Mice were anesthetized with 375 mg/kg of body weight with Avertin
(97% 2,2,2-treidromoethanol; Aldrich) and injected intratracheally (i.t.)
with a 20-l inoculum. The challenge inoculum (106 CFU/mouse of P.
aeruginosa) was established by pilot experiments. Mice were sacrificed
after 8, 20, or 36 h of infection. Mortality was recorded every 6 to 12 h.
BALF and lung analysis. The bronchoalveolar lavage was performed
three times with 1 ml of RPMI 1640 medium with protease inhibitors
(complete tablets [Roche Diagnostic] and phenylmethylsulfonyl fluoride
[PMSF; Sigma])with a 22-gauge venous catheter. Total cells present in the
bronchoalveolar lavage fluid (BALF) were counted, and a differential cell
count was performed on cytospins stained with Diff Quick (Dade, Bio-
map, Italy). Lungs were removed and homogenized in 1ml of phosphate-
FIG 1 Tir8 expression in infected lungs and neutrophils. (A and B) Immunostaining analysis for Tir8 in lung sections of noninfectedmice (A) andmice infected by P.
aeruginosa (106 CFU/mice; 20 h postinjection) (B) (original magnification,40). Lungs were fixed in 4% PFA overnight at 4°C and paraffin embedded. Bronchial
epithelium (), blood endothelial cells (arrows), and leukocytes (arrowheads) are indicated. (C) Tir8 mRNA expression by reverse transcription-PCR in total lung of
noninfected mice (Control) and at 20 h postinjection of P. aeruginosa (106 CFU/mice). (D) Tir8 mRNA expression by reverse transcription-PCR in bone marrow
neutrophils (polymorphonuclear leukocytes) of noninfected mice (Control) and in BALF polymorphonuclear leukocytes at 20 h postinjection of P. aeruginosa (106
CFU/mice). Data shown are from one experiment of two performed with similar results. , P 0.05 versus control (two-tailed Student’s t test; n 5).
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buffered saline (PBS) with Ca2/Mg2-containing protease inhibitors.
BALF and lung samples were serially diluted 1:10 in PBS and plated for
CFU counts. Samples were then centrifuged, and supernatants were
stored at20°C for quantification of total protein content with Coomas-
sie Plus protein assay reagent (Thermo Scientific, Rockford, IL) or for
cytokine analysis. Murine cytokines and chemokines (gamma interferon
[IFN-], tumor necrosis factor alpha [TNF-], IL-1, IL-6, IL-2, IL-
12p70, IL-23, IL-17, IL-4, IL-5, transforming growth factor  [TGF-],
IL-10, keratinocyte-derived chemokine [KC]/CXCL1, MIP-2/CXCL2,
IP10/CXCL10, JE/CCL2, MIP1/CCL3, RANTES/CCL5, and eotaxin/
CCL11) were measured in whole lung tissue homogenates and serum by
enzyme-linked immunosorbent assay ([ELISA] R&D DuoSet ELISA De-
velopment Systems), according to the manufacturer’s instructions.
To analyze the myeloperoxidase (MPO) activity, pellets from lung
homogenateswere resuspended andhomogenized in0.5%cetyltrimethyl-
ammonium chloride (CTAC) (4 l/mg of tissue) and centrifuged. The
clear extract (50 l) was mixed with an equal volume of 3 mM TMB
(3,3=,5,5=-tetramethyl-benzidine dihydrochloride; Sigma-Aldrich) for 2
min. The reaction was stopped by the addition of 100 l of 2 M H2SO4.
The optical density (OD) was measured at 450 nm.
Histological and immunohistochemical examination. Lungs were
removed, fixed in 4% paraformaldehyde (PFA) for at least 24 h, and
embedded in paraffin. Consecutive sections from the middle of the five
lung lobes were stained by hematoxylin and eosin (H&E) and exam-
ined blindly by a pathologist (M. Nebuloni). The presence of acute
alveolitis and bronchitis was used as a parameter for the comparative
analysis, with a score ranging (degree of inflammation) from 0 to 3 (0,
no lesions; 1, low; 2, moderate; and 3, severe).
For Tir8 immunohistochemistry, sections were deparaffinized and
treated with 2% H2O2 for 20 min to block endogenous peroxidase. For
antigen retrieval, sections were pretreated in a microwave oven (two cy-
cles for 3 min each at 800W, in 0.25 mM EDTA buffer, pH 8.0). Nonspe-
cific binding sites were blocked with a solution of 1% bovine serum albu-
min, 0.02% NP-40, and PBS, pH 7.0. Then, sections were incubated with
goat anti-murine SIGIRR ([mSIGIRR] 100 g/ml; R&D Systems) for 2 h
at room temperature. The reaction was revealed by the application of an
anti-goat polymer kit (Biocare Medical) and 3,3=-diaminobenzidine
(DAB) free base as the chromogen.
Quantitative PCR of whole-lung and neutrophil mRNAs. Lungs
were removed immediately after euthanasia, preserved in RNAlater
FIG 2 Increased susceptibility to P. aeruginosa lung infection of Tir8 deficient mice. (A) Survival of Tir8/ and Tir8/mice infected i.t. by P. aeruginosa (106
CFU/mice). Data shown were pooled from three experiments performed with 8 to 10mice per group per experiment. , P 0.0001 (two-tailed log rank test).
(B) Bacterial load. Lungs and BALF fromTir8/ (open symbols) andTir8/ (filled symbols)mice were collected at 8 and 20 h after injection and processed for
CFU counts. Data shownwere pooled from two experiments performed at 8 h or three experiments at 20 hwith 8 to 12mice per group. Themean value is shown.
, P 0.01; , P 0.05 (two-tailed Student’s t test).
Véliz Rodriguez et al.
102 iai.asm.org Infection and Immunity
 o
n
 January 19, 2016 by PRO
FESSO
R O
F RESEARCH
http://iai.asm
.org/
D
ow
nloaded from
 
(Ambion, Inc./Applied Biosystems, Foster City, CA), and stored at
20°C until homogenization and total RNA extraction by TRIzol (In-
vitrogen, San Diego, CA).
Bone marrow cells were separated by centrifugation at 1,000 to
1,200  g for 30 min at room temperature over discontinuous Percoll
gradients consisting of 55% (vol/vol) and 80% (vol/vol) Percoll in PBS.
Eighty percent pure neutrophils were recovered from the interface frac-
tions. Neutrophils were then isolated by using an anti-Ly6G Micro Bead
kit (Miltenyi Biotec, Bergisch Gladbach, Germany).
A reverse transcription reaction from 1g of lung or neutrophil RNA
template was done using a High Capacity cDNA Archive kit (Applied
Biosystems) according to the manufacturer’s instructions. The sequences
of primer pairs specific for the Tir8 gene sequence (Invitrogen) were de-
signed with Beacon Designer (Premier Biosoft International). Real-time
PCR was performed using the SYBR green PCR Master Mix (Applied
Biosystems) with a 7900HT Fast Real-Time PCR system (Applied Biosys-
tems). Data were normalized for -actin expression. Analysis of all sam-
ples was performed in triplicate. The following primer sequences were
used for Tir8: forward, 5=-TGCTTTGGAAGCCTGGCTCCGT-3=; re-
verse, 5=-GGTTTCCTGCAGTGGAGTTGGT-3=.
Analysis of apoptosis. Apoptosis of BALF neutrophils was deter-
mined by flow cytometry using rat IgG2a anti-mouse Ly6G-
phycoerythrin ([PE] BD Pharmingen, San Diego, CA), annexin
V-allophycocyanin ([APC] BD Pharmingen, San Diego, CA), and pro-
pidium iodide (PI) (Apoptosis Detection Kit; Immunostep Research,
Salamanca, Spain) according to the manufacturer’s instructions. Multi-
color flow cytometric analyses were performed using a FACS
(fluorescence-activated cell sorter) Canto (BD Biosciences) instrument
equipped with a solid diode laser (488 nm, 20 mW) and an Elio-Neon
laser (633 nm, 17 mW).
The evaluation of apoptosis in tissues was performed on paraffin-
embedded tissues using a QIA33 FragEL DNA Fragmentation Detection Kit
(using colorimetric detection and terminal deoxynucleotidyltransferase
[TdT] enzyme for a TdT dUTP-biotin nick end labeling [TUNEL] assay;
Calbiochem/Merck Chemicals, Nottingham, United Kingdom). The per-
centage of apoptotic cells per field (magnification,40)was analyzed in each
mouse.
Statistical analysis. Five to 12 animals per experimental group were
used throughout the study.Data are expressed asmeans standard errors
(SE), and two-tailed or one-tailed Student’s t or log rank tests were used as
specified the legends. Experiments were repeated two to five times.
RESULTS
Tir8 deficiency impairs the resistance to acute P. aeruginosa
lung infection. To address the potential involvement of Tir8 in P.
aeruginosa lung infection, we first analyzed the expression of Tir8
at the protein and mRNA levels in the lungs of control and in-
fectedmice. As shown in Fig. 1A andB, the immunohistochemical
analysis indicated that, in the lung, Tir8 was expressed by bron-
chial epithelium, blood endothelial cells, and leukocytes in both
noninfected (Fig. 1A) and infected (Fig. 1B)mice. In the latter, the
inflammatory infiltrate expressed Tir8. Under these experimental
conditions, the expression of Tir8 protein was not modified 20 h
after infection. In contrast, the Tir8 mRNA level in the lung was
significantly reduced at 20 h postinjection compared to the level in
noninfected lungs (Fig. 1C). Similarly, BALFneutrophils collected
at 20 h postinjection had significantly lower Tir8 mRNA levels
than noninfected bone marrow neutrophils (Fig. 1D), in agree-
ment with previous observations (35).
Next, Tir8/ and Tir8/ mice were infected i.t. with 106
PAO1 CFU. This dose caused mortality in 22% of Tir8/ mice
over a 96-h period. As shown in Fig. 2A, PAO1 infection in
Tir8/ mice resulted in increased mortality (61% in 48 h and
87% in 96 h). As reported in Fig. 2B, showing the results from
three pooled experiments with 6 to 12 mice per group, increased
susceptibility of Tir8/ mice was associated with significantly
higher lung and BALF bacterial loads, both at 8 h and 20 h postin-
jection. In particular, in the lungs of Tir8/ mice, the bacterial
load was 10-fold higher at 20 h postinfection (3.4 106 1.02
106 CFU versus 35.78  106  8.8  106 CFU in Tir8/ and
Tir8/, respectively [mean SE]; P 0.001) and 5-fold higher
at 36 h postinfection (4.8  107  1.8  107 CFU versus 2.5 
108  8.0  107 CFU, in Tir8/ and Tir8/, respectively; P 
0.03, one experiment performed; n 8).
We next measured local and systemic levels of proinflamma-
tory cytokines and chemokines. In noninfected mice, pulmonary
levels of IL-1, IL-6, TNF-, MIP-2/CXCL2, KC/CXCL1, and
JE/CCL2 were similar in Tir8/ and Tir8/ mice. At 8 h after
infection, levels of proinflammatory cytokines (IL-1, IL-6, and
TNF-) and chemokines (KC/CXCL1, MIP-2/CXCL2, and JE/
CCL2) in lung homogenates were elevated compared to levels in
noninfected mice, but they were similar in Tir8/ and Tir8/
mice. At 20 h, the levels of IL-1, IL-6, KC/CXCL1, MIP-2/
CXCL2, and JE/CCL2 were reduced compared to the levels ob-
served at 8 h postinfection, but in Tir8/mice they were signif-
icantly higher than inTir8/mice (Table 1). At 20 h, higher levels
of IFN-, IL-23,MIP-1/CCL3, RANTES/CCL5, eotaxin/CCL11,
and IL-10 were also observed in Tir8/ homogenate compared
to levels in Tir8/ homogenate. In contrast, no differences
TABLE 1 Cytokine and chemokine levels in P. aeruginosa lung infection
Cytokine or chemokine
Amt (ng/ml) in lung
homogenate of:a
P valueb
Tir8/
mice
Tir8/
mice
Proinflammatory cytokines
IFN 0.17 0.03 0.30 0.03 *
TNF- 3.95 0.78 8.66 0.83 ***
IL-1 9.96 2.00 19.69 1.70 **
IL-6 2.45 0.61 6.04 0.52 ***
IL-2 0.12 0.05 0.11 0.04 NS
IL-12p70 0.20 0.05 0.21 0.04 NS
IL-23 0.15 0.07 0.83 0.14 ***
Th2 cytokines
IL-4 0.44 0.04 0.41 0.03 NS
IL-5 0.06 0.01 0.05 0.01 NS
Regulatory cytokines
IL-10 0.24 0.05 0.54 0.08 **
TGF- 4.16 0.76 4.49 0.67 NS
Chemokines
KC/CXCL1 5.49 1.04 13.68 1.35 ***
MIP-2/CXCL2 8.06 2.39 19.55 2.04 **
IP-10/CXCL10 7.06 0.39 7.95 0.35 NS
JE/CCL2 0.52 0.06 0.91 0.12 **
MIP-1/CCL3 1.17 0.26 1.94 0.16 *
RANTES/CCL5 5.39 0.42 7.65 0.88 *
EOTAXIN/CCL11 0.75 0.14 1.98 0.15 ***
a Cytokine and chemokine levels were analyzed 20 h after i.t. injection of P. aeruginosa
(106 CFU/mice). Data shown are from one experiment of two performed with similar
results. Values are means SE (n 10 per group).
b Significance was determined by a two-tailed Student’s t test, as follows: ***, P
0.0001; **, P 0.005; *, P 0.05; NS, nonsignificant.
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were observed in IL-2, IL-4, IL-12p70, or TGF- levels. At the
systemic level, TNF-, IL-6, KC/CXCL1, and MIP-2/CXCL2
levels were significantly higher in Tir8/mice than in Tir8/
mice (Table 2).
Histologically, we observed diffuse signs of pneumonia in both
Tir8/ and Tir8/mice. At 8 h as well as at 20 h and 36 h after
inoculation with 106 P. aeruginosa CFU, lungs appeared inflamed
and hemorrhagic, showed hyperemia, perivasal edema, and an
important interstitial and alveolar infiltrate, composed mostly of
neutrophils (Fig. 3A and B and data not shown), but we did not
observe differences in the severity of lung lesions or in the intensity
and composition of the inflammatory infiltrate in the two groups,
and the scores were comparable. Consistently, the injection of P.
aeruginosa induced similar increased MPO activity in the lungs
after 8 h and 20 h in both groups (Fig. 3C).
To analyze the pneumonia-associated edema, wemeasured the
lung wet weight and the protein content in BALF of Tir8/ and
Tir8/ mice. P. aeruginosa-induced pneumonia caused a severe
increase in thewet lungweight (60%after 8 h and 100%after 20 h)
and vascular leakage in both groups of mice compared to nonin-
fected mice. However, we did not observe significant differences
between Tir8/ and Tir8/ mice for either parameter (not
shown).
Total and differential cell counts performed on BALF at 8 h
postinjection showed an important leukocyte recruitment, com-
posed mostly of neutrophils, which further increased at 20 h
TABLE 2 Systemic cytokine and chemokine levels in P. aeruginosa
lung infection
Cytokine or chemokine
Amt (ng/ml) in serum of:a
P valueb nc
Tir8/
mice
Tir8/
mice
Proinflammatory cytokines
TNF- 13.23 2.6 20.26 3.1 * 7
IL-6 1.1 0.22 3.1 0.63 * 15
Chemokines
KC/CXCL1 2.94 0.84 8.01 2.45 † 10
MIP-2/CXCL2 0.09 0.03 0.33 0.09 * 10
a Cytokine and chemokine levels were analyzed at 8h (TNF-) or 20 h after i.t. injection
of P. aeruginosa (106 CFU/mice). Values are means SE.
b Significance was determined by a Student’s t test as follows: *, P 0.05, two-tailed
test; †, P 0.05, one-tailed test.
c n, number of mice.
FIG 3 Histological analysis of P. aeruginosa-infected lungs. Representative H&E-stained lung sections of Tir8/ (A) and Tir8/ (B) mice 20 h after infection by P.
aeruginosa (106 CFU/mice). Lungs were fixed in 4% PFA overnight at 4°C and paraffin embedded. BR, acute bronchitis; , acute granulocytic alveolitis (original
magnification,40). (C)MPOactivity in the lungs ofTir8/ andTir8/untreatedmice (Ctr) and8 and20h after i.t. injectionofP. aeruginosa (106CFU/mice).Data
shown (means SE)were pooled from two to four experiments performedwith 5 to 12mice per group, at each time point. (D) Percentage of annexinV/PI/Ly6G
cells in BALF 20 h after the infection in Tir8/ and Tir8/mice. Data are from three pooled experiments. , P 0.05 (two-tailed Student’s t test).
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postinjection. However, total and differential cell counts were
similar in Tir8/ and Tir8/mice at both time points analyzed
(data not shown). In contrast, we observed increased annexin V/
PI/Ly6G cells in Tir8/ BALF by FACS analysis (10.08% 
0.6% versus 13.9% 1.5% in Tir8/ and Tir8/mice, respec-
tively; values are mean  SE of 15 mice from three experiments;
P 0.04) (Fig. 3D).
Involvement of IL-1RI-dependent inflammation in the in-
creased susceptibility ofTir8/mice toP. aeruginosa.TIR8 is a
member of the ILR family. To assess the actual role of IL-1 in the
phenotype observed during P. aeruginosa lung infection, we gen-
erated Tir8/ IL-1R/ mice and infected them with P. aerugi-
nosa i.t. As shown in Fig. 4A, the susceptibility to mortality of
Tir8/ mice was significantly reduced by the absence of IL-1RI
(46% mortality in Tir8/ IL-1R/mice versus 87% in Tir8/
mice; P 0.005) in a 96-h period.
Moreover, as shown in Fig. 4B, at 20 h postinjection the bacte-
rial load in BALF and lungs of Tir8/ IL-1R/mice was signif-
icantly reduced compared to that of Tir8/ mice and was com-
parable to bacterial loads of Tir8/ IL-1R/ and IL-1R/mice
(P is nonsignificant). In particular, the mean lung CFU count of
Tir8/ IL-1R/mice was 3.5 104 3 104 ( SE), whereas
the mean lung CFU count of Tir8/mice was 2.6 106 0.8
106 ( SE; P 0.002).
We next analyzed cytokine and chemokine levels in lungs
and serum of the four groups of mice at 20 h postinfection. As
reported in Table 3, the deficiency of IL-1RI abated the exces-
sive production of proinflammatory cytokines and chemokines
observed in Tir8/ mice. In particular, TNF-, IL-1, IL-6,
KC/CXCL1, MIP-2/CXCL2, and JE/CCL2 levels were signifi-
cantly lower in Tir8/ IL-1R/ lung homogenates than in
those of Tir8/ mice. At the systemic level, IL-1RI deficiency
reduced the excessive production of IL-1, IL-6, KC/CXCL1,
MIP-2/CXCL2, and JE/CCL2, thus suggesting that IL-1 plays
a major role in the systemic inflammatory response of Tir8/
mice to the infection. Moreover, IL-6, MIP-2/CXCL2, and
JE/CCL2 systemic levels were dramatically lower in IL-1R/
and also in Tir8/ IL-1R/ mice than in wild-type mice,
FIG 4 IL-1RI deficiency rescues the increasedmortality and impaired bacterial clearance ofTir8/mice. (A) Survival ofTir8/ IL-1R/,Tir8/, IL-1R/,
andTir8/ IL-1R/mice infected i.t. with P. aeruginosa (106 CFU/mice). Data shownwere pooled from three experiments performedwith 10mice per group.
, P 0.0001; , P 0.05 versus Tir8/ IL-1R/; §§, P 0.005 versus Tir8/ IL-1R/ (two-tailed log rank test). (B) Bacterial load in lungs and BALF
of Tir8/ IL-1R/, Tir8/, IL-1RI/, and Tir8/ IL-1R/mice 20 h after i.t. injection by P. aeruginosa (106 CFU/mice). Data shown were pooled from
two experiments performed with 5 to 8 mice per group. Mean values are shown. A two-tailed Student’s t test was used.
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suggesting that, during the infection, the production of these
cytokines is IL-1RI dependent (Table 4).
As reported above (Fig. 3A and B), diffuse and severe acute
granulocytic alveolitis and bronchitis were observed in Tir8/
and Tir8/ mice (Fig. 5A and B, respectively). In Tir8/ IL-
1R/ lungs (Fig. 5D and E), alveolitis and bronchitis scores were
significantly lower than in the wild-type, Tir8/, and IL-1R/
mice. In agreement, the MPO activity of Tir8/ IL-1R/ mice
was significantly lower than that observed in wild-type or Tir8/
mice (Fig. 5F). Similarly, the wet weights of Tir8/ IL-1R/
lungs were significantly lower than those of wild-type andTir8/
mice (data not shown).
DISCUSSION
In the present work, we examined the role of TIR8/SIGIRR, a
negative regulator of the ILR/TLR superfamily, in innate resis-
tance to acute P. aeruginosa lung infections. We found that Tir8
deficiency caused an increased susceptibility to acuteP. aeruginosa
lung infection, in terms of mortality and bacterial load, which was
associated with an exaggerated production of proinflammatory
cytokines (TNF-, IL-1, IL-6, and IFN-) and chemokines
(CXCL1,CXCL2, andCCL2)within the pulmonary compartment
and systemically. IL-1RI deficiency reverted these phenotypes and
was associatedwith significantly less severe lung lesions than those
observed inTir8/mice. These findings suggest thatmortality of
Tir8/ mice was caused by an excessive local and systemic in-
flammatory response and that the unregulated IL-1RI-dependent
signaling played a major role in the deleterious effect of Tir8 defi-
ciency.
The susceptibility to P. aeruginosa infection and lung injury are
due either to the toxic effect of a virulence factor or to the severe
inflammation resulting from the response to virulence factors,
including type III secreted toxins (TTSTs), lipopolysaccharide
(LPS), phospholipase C, and flagellin (5, 23, 46, 55, 61). The rele-
vance of the different players involved in the pathogenesis of the
infectionmay differ depending on the strain involved. In the pres-
ent study, we used the PAO1 reference strain, whose LPS structure
and virulence are similar to those of clinical strains isolated at the
early stage of CF chronic infection (7, 10).
In the innate response to P. aeruginosa, TLR2 and TLR4, rec-
ognizing LPS, and TLR5, responsible for flagellin sensing (38, 40),
are involved in the production of inflammatory mediators, play-
ing nonredundant roles in the infection (39). In agreement, the
development of an early host response to P. aeruginosa lung infec-
tion is critically dependent onMyD88 inmice (36) and on NF-B
(9). On the other hand, TLR2- and TLR4-dependent signaling has
been implicated in impairing neutrophil effector functions, such
as migration to inflammatory sites through CXCR2 internaliza-
tion (2), phagocytosis, and bacterial killing, as well as in inducing
apoptosis and bonemarrowneutrophil exhaustion (32, 43, 44). In
particular, inhibition of neutrophil migration and induction of
neutrophil apoptosis are two ways in which TLR agonists exert
detrimental effects in sepsis, enhancing bacterial proliferation and
mortality (2, 44). Altogether, these studies provide support to
anti-TLR treatment strategies for Gram-negative sepsis (24, 44).
We speculate that some of the phenotypes observed in Tir8/
mice in this study could be related to excessive TLR2 and TLR4
activation, in particular, defective bacterial clearance, neutrophil
lung recruitment comparable to that of wild-type mice despite
high chemokine levels, and increased neutrophil apoptosis.
Proinflammatory cytokines are key mediators of innate de-
fense in pneumonia models, such as Klebsiella pneumoniae or
Streptococcus pneumoniae (48). However, several experiments
have demonstrated that some of these mediators play a delete-
rious role in the host defense during Pseudomonas pneumonia,
inhibiting bacterial clearance. Actually, decreased susceptibil-
ity to the infection was observed in mice deficient in IFN-
receptor (50), type 1 TNF receptor (TNFR1) (53), or IL-18
(48), whereas IL-10 played a protective role (27, 47). The role
of IL-1 in P. aeruginosa infection has been widely studied in
the context of chronic (41) and acute (49) infections. Reiniger
et al. (41) found that a lack of IL-1R led to increased lung
colonization upon oral inoculation of P. aeruginosa, suggesting
that a moderate amount of IL-1 might play a beneficial role
during a chronic infection. In contrast, Schultz et al. reported
that the absence of the IL-1R-dependent signal improved the
host defense against acute lung infection with P. aeruginosa,
decreased influx of neutrophils in bronchoalveolar lavage flu-
ids, and reduced levels of cytokines (TNF- and IL-6) and
chemokines (MIP-2 and KC) in the lungs (49).
TABLE 4 Effect of IL-1RI-deficiency on systemic levels of
proinflammatory mediators in Tir8/mice
Cytokine or
chemokine
Amt (ng/ml) in serum of:a
Tir8/
IL-1R/
mice Tir8/mice
IL-1R/
mice
Tir8/
IL-1R/
mice
Proinflammatory
cytokines
IL-1 0.16 0.08 0.56 0.19* 0.14 0.04 0.22 0.04§
IL-6 2.37 1.24 4.74 1.63 0.32 0.19§ 0.03 0.02†
Chemokines
KC/CXCL1 0.89 0.23 5.49 1.35** 4.29 2.34 0.51 0.21‡
MIP-2/CXCL2 1.18 0.78 7.30 1.66** 0.04 0.03† 0.03 0.02‡
JE/CCL2 1.23 0.59 5.03 2.19* 0.54 0.3 0.10 0.03§
a Cytokine and chemokine serum levels analyzed by ELISA 20 h following P. aeruginosa
lung injection (106 CFU/mice). Data represent means SE of 5 to 10 mice per group.
Significance was determined by a two-tailed Student’s t test as follows: *, P 0.05; **,
P 0.005 versus Tir8/ IL-1R/ group; §, P 0.05; †, P 0.005; ‡, P 0.0001
versus Tir8/ group.
TABLE 3 Effect of IL-1RI-deficiency on lung cytokine and chemokine
levels in Tir8/mice
Cytokine or
chemokine
Amt (ng/ml) in lung homogenate of:a
Tir8/ IL-
1R/mice Tir8/mice
IL-1R/
mice
Tir8/ IL-
1R/mice
Proinflammatory
cytokines
TNF- 4.74 1.23 13.19 3.70* 10.03 3.84 5.62 1.78§
IL-1 5.33 1.20 10.99 2.55* 4.50 1.09§ 5.04 1.33§
IL-6 1.40 0.41 7.17 2.46* 0.90 0.37§ 0.76 0.22†
IL-17 0.47 0.14 0.97 0.16* 0.59 0.12 0.80 0.16
IL-23 0.45 0.18 1.04 0.19* 0.61 0.12 1.29 0.11
Chemokines
KC/CXCL1 11.93 3.38 30.91 5.14** 9.52 1.9‡ 10.36 2.8‡
MIP-2/CXCL2 3.97 0.62 9.87 2.29* 1.97 0.4 2.96 0.32†
JE/CCL2 0.49 0.14 1.81 0.42* 0.80 0.32 0.35 0.04†
a Cytokine and chemokine levels were analyzed by ELISA in lung homogenates at 20 h
following P. aeruginosa lung injection (106 CFU/mice). Data shown are from two
pooled experiments. Values are means SE (n 10 to 18 per group). Significance was
determined by a two-tailed Student’s t test as follows: *, P 0.05; **, P 0.005 versus
Tir8/ IL-1-R/ group; §, P 0.05; †, P 0.005; ‡, P 0.0001 versus Tir8/
group.
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Several studies support these data and suggest that the IL-1
systempotentially plays a detrimental effect in P. aeruginosa infec-
tion and sepsis (11, 58).P. aeruginosa triggers activation of the acid
sphingomyelinase and the release of ceramide in sphingolipid-
rich rafts, which are required to internalize the pathogen, induce
apoptosis, and regulate cytokine production. Failure to generate
ceramide-enriched membrane platforms in infected cells results
in an unabated inflammatory response, massive release of IL-1,
and septic death of mice, which are prevented by IL-1 neutraliz-
ing antibodies (19, 56). In the same line, a deficiency in the tran-
FIG 5 Effect of IL-1RI-deficiency on lung pathology of Tir8/mice. (A to D) H&E-stained lung sections of Tir8/ IL-1R/ (A), Tir8/ (B), IL-1R/ (C),
andTir8/ IL-1R/ (D)mice at 20 h after i.t. injection of P. aeruginosa (106 CFU/mice). Lungs were fixed in 4%PFA overnight at 4°C and paraffin embedded.
, diffuse and severe acute granulocytic alveolitis; , small and focal areas of granulocytic alveolar inflammation; Br, bronchitis; arrow, normal bronchus
(original magnification,40). (E) Histological score obtained analyzing the five lobes of fourmice per group at 20 h after the infection. Alveolitis and bronchitis
were scored on a scale from 0 to 3. A two-tailed Student’s t test was used. (F) MPO activity in the lung of Tir8/ IL-1RI/, Tir8/, IL-1RI/, and Tir8/
IL-1RI/mice 20 h after infection. Data shown were pooled from three experiments performed with 10 mice per group, respectively. A two-tailed Student’s t
test was used.
Tir8 in P. aeruginosa Lung Infection
January 2012 Volume 80 Number 1 iai.asm.org 107
 o
n
 January 19, 2016 by PRO
FESSO
R O
F RESEARCH
http://iai.asm
.org/
D
ow
nloaded from
 
scriptional repressor Gfi1 results in an uncontrolled release of
TNF- and IL-1 , leading to P. aeruginosa-induced septic shock,
which was inhibited by TNF- and IL-1 neutralization (20).
A rapid innate response is directed specifically at P. aeruginosa
bacteria expressing a translocation-competent type three secre-
tion system (TTSS), a virulence factor involved in inflammasome
activation (22). This response, which requires host caspase-1 and
is accompanied by increased IL-1 production, is associated with
the recruitment of neutrophils to the airways and results in rapid
bacterial clearance (60). Indeed, IPAF and ASC are critical regu-
lators of IL-1 and IL-18 production by P. aeruginosa-infected
alveolar macrophages (13, 46, 55, 58). However, the P. aeruginosa
TTSS has been associated with increased virulence in murine
pneumonia models and with worse clinical outcomes in human
patients with ventilator-associated pneumonia (23, 45). Our re-
sults are in line with all of these studies suggesting that excessive
inflammatory responses may be responsible for increased suscep-
tibility to this infection, impaired neutrophil effector functions,
and inhibited microbial clearance.
That the histological score observed in Tir8/ IL-1R/mice
was better than that of other experimental groups suggests that the
pathways controlled by TIR8/SIGIRR and the IL-1RI-dependent
pathway do not overlap. Indeed, since TIR8 controls both IL-1R-
and TLR-dependent signaling, we speculate that increased TLR
activity combined with inhibited IL-1RI-dependent inflamma-
tion may be beneficial for the host in this model.
Some of the phenotypes presented in this study, such as in-
creased local and systemic cytokine production and the beneficial
effect of blocking IL-1, are in agreementwith those observed in the
model of pulmonary tuberculosis, where Tir8 deficiency was as-
sociated with increased inflammatory responses leading to death
despite normal control of the bacterial load (15). Signaling
through IL-1R and TNFR1 is essential in regulating granuloma
formation and persistence and necessary for host resistance to
Mycobacterium tuberculosis (26, 42). However, the phenotype of
Tir8-deficient mice could be reverted by blocking IL-1 and
TNF-, suggesting that Tir8 plays a nonredundant role in the
control of the balance between protective immune responses and
immunopathology in pulmonary tuberculosis (3, 15). In the same
vein, Tir8-deficientmice showed increased susceptibility to fungal
infections due toCandida albicans or Aspergillus fumigatus, which
was associated with increased fungal growth and heightened
harmful Th17 cell responses (6, 21, 34, 62). In the absence of Tir8,
this abnormal polarization was dependent on increased IL-1 sig-
naling, in line with the evidence that IL-1 plays a key role in the
differentiation of Th17 cells from naïve precursors (1).
In the absence of TIR8/SIGIRR, the exacerbated inflammatory
response to P. aeruginosa lung infection was associated with high
levels of proinflammatory cytokines, which contribute signifi-
cantly to lethality in septic shock syndrome (TNF-, IL-1, IL-6,
IL-17, IL-23, IFN-), whereas the lung histological score did not
suggest increased tissue damage. In IL-1RI- and Tir8-deficient
mice, we observed a general reduction of most of all these proin-
flammatory mediators, suggesting that the deficiency of IL-1R-
dependent signaling prevented the deleterious effect of these me-
diators. Interestingly, in a P. aeruginosa sepsis model,
administration of IL-23-neutralizing antibody was sufficient to
reduce mortality and decrease circulating levels of the pathoge-
netic cytokines, TNF- and IFN- (4).
These results strongly suggest that in this model of severe in-
fection by P. aeruginosa, the lack of a negative regulator of TLR
and IL-1R results in exacerbated inflammation, which is detri-
mental for the host, and that an IL-1-dependent inflammatory
cascade plays a critical role in the balance between protective in-
nate responses and excessive local and systemic inflammatory re-
sponses.
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